SEATTLE -- Weight loss drugs have gained momentum as treatment for obstructive sleep apnea (OSA) at sleep clinics across the country -- although patients appear more ready for the shift than the ...

Real-world results for blockbuster weight-loss meds like Ozempic, Wegovy and Zepbound aren't as impressive ... when it comes to treatment for sleep apnea in those with obesity, a new study reports.

The researchers found that, for the treatment of comorbid obesity and obstructive sleep apnea, patients leaned toward tirzepatide while providers favored CPAP.

Health News // 1 day ago Study: Real-world results of GLP-1 drugs don't match trials Real-world results for blockbuster weight-loss meds like Ozempic, Wegovy and Zepbound aren't as impressive as ...

Dr. Cissy Kityo Mutuluuza is a physician, epidemiologist, medical researcher, and the executive director of the Joint ...

Eli Lilly is claiming another victory in a head-to-head trial comparing its weight-loss drug Zepbound to its main ... obstructive sleep apnoea, or cardiovascular disease, but without diabetes.

The results of the first head-to-head trial of Lilly's dual GLP-1/GIP agonist Zepbound (tirzepatide ... obstructive sleep apnoea, or cardiovascular disease, but who did not have diabetes.

Smoky air often has obvious short-term health effects like coughing and sore throat, but it can also have long-term impacts ...

Communities across Asia's Himalayan Hindu Kush region face heightened disaster risks this monsoon season with temperatures ...

Consumer prices were only slightly affected by President Donald Trump’s tariffs in May, according to new numbers from the U.S. Bureau of Labor Statistics.

Sleep apnea and weight ... Zepbound is a prescription injection used for weight loss ... There is some debate as to whether GLP-1 agonist drugs like Wegovy can lead to unhealthy muscle mass loss ...

An athlete who was diagnosed with a brain tumor after a seizure in his sleep had to relearn how to walk again - and is ...